Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Patent
1989-08-11
1993-02-09
Draper, Garnette D.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
530350, 530395, 530820, 435 695, 424 851, 930120, C07K 1300, A61K 3702
Patent
active
051854317
ABSTRACT:
A recombinant natural killer cell activating factor is disclosed, preferably having a peptide of the following amino acid sequence in its molecule. The invention provides a cDNA coding for a recombinant natural killer cell activating factor, a expression plasmid involving the cDNA, a host transformed with the plasmid, an antitumor agent containing the recombinant natural killer cell activating factor and a pharmaceutical composition which comprises a pharmacologically effective amount of the antitumor agent and a pharmacologically acceptable carrier.
REFERENCES:
McGrogan et al., J. Exp. Med., 168, 2295-2308 (1988).
Chemical Abstracts 103:52562z (1985).
Talmadge et al., Nature, vol. 284, pp. 622-624 (Apr. 17, 1980).
T. Maniatis et al., Molecular Cloning, Cold Spring Harbor Lab., pp. 320-321 (1982).
Okayama et al., Mol. and Cellular Biology, vol. 3, No. 2, pp. 280-289 (Feb. 1983).
Gluzman, Cell, vol. 23, pp. 175-182 (Jan. 1981).
Subramani et al., Mol. and Cellular Biology, vol. 1, No. 9, pp. 854-864 (Sep. 1981).
Southern et al., J. of Molecular and Applied Genetics, vol. 1, No. 4, pp. 327-341 (1982).
Kao et al., Proc. N.A.S., vol. 60, pp. 1275-1281 (1968).
Smith, Nucleotide Sequencing Techniques, vol. 58, pp. 560-581.
Galfre et al., Methods in Enzymology, vol. 73, pp. 3-47 (1981).
Sanger et al., Proc. Natl. Acad. Sci. USA, vol. 74, No. 12, pp. 5463-5467 (Dec. 1977).
Yokota et al., Proc. Natl. Acad. Sci. USA, vol. 82, pp. 68-72 (Jan. 1985).
Chirgwin et al., Biochemistry, vol. 18, No. 24, pp. 5294-5299 (1979).
Gubler et al., Gene, vol. 25, pp. 263-269 (1983).
Asada et al., Cellular Immunology, vol. 77, pp. 150-160 (1983).
Higuchi et al., Cellular Immunology, vol. 78, pp. 257-265 (1983).
Herberman et al., Immunological Rev., vol. 44, pp. 43-70 (1979).
Rygaard et al., Transplant. Rev., vol. 28, pp. 43-61 (1976).
Lathe, J. Mol. Biol., vol. 183, pp. 1 12 (1985).
Natural Killer, vol. 2, No. 2, pp. 70-75 (1984).
Shitara et al., The Journal of Immunology, vol. 134, No. 2, pp. 1039-1047 (Feb. 1985).
Kobayashi et al., The J. of Immunology, vol. 128, No. 6, pp. 2714-2718 (Jun. 1982).
Vose et al., The J. of Immunology, vol. 130, No. 2, pp. 768-772 (Feb. 1983).
Domzig et al., The J. of Immunology, vol. 130, No. 4, pp. 1970-1973 (Apr. 1988).
Science, vol. 183, pp. 534-537 (1973)--Stutman.
Kumagai et al., Japanese Handbook, vol. 42, pp. 859-868 (1984).
Shitura et al., J. Immunol 134(2) 1985, pp. 1039-1047, Prenderyast et al., J. Biol Chem. 263, 1988, pp. 12559-12563.
Hasegawa Yoshikazu
Ohya Yukio
Osawa Toshio
Seto Toshio
Shikata Yasushi
Draper Garnette D.
Eisai Co. Ltd.
LandOfFree
Recombinant natural killer cell activator does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant natural killer cell activator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant natural killer cell activator will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-326300